Therapeutics

Automated synthesis of gene fragments using the BioXp™ system enables overnight production of error-corrected, de novo synthetic genes of up to 7,200 base pairs in length

Identifying adaptive signaling pathways for designing improved targeted therapies

Novel media supports automated T-cell expansion to deliver scalable, cost-effective cell therapy treatments  

The frozen Leukopaks will enable long-distance shipping of leukapheresis products without the concern of reduced cell viability encountered with fresh Leukopaks

Robust and accurate HCP measurement is crucial throughout biologics development

FAQs about improving risk mitigation by challenging host cell protein assays

Find solutions, expertise, and support to advance and accelerate therapeutics

Antibody validation and quality control strategies ensure high specificity and reproducibility for optimal performance

In this Q&A, Craig Crews, PhD, discusses the discovery and development of proteolysis targeting chimeras, a new modality that is being explored for both drug discovery and therapeutic application

Prevent costly HCP underestimation with a robust CHO Supernatant ELISA Kit